We are live on ! Find out more
HHS icon

Harte-Hanks
HHS

24 hedge funds and large institutions have $3.82M invested in Harte-Hanks in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 2124 (+3)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

43% less capital invested

Capital invested by funds: $6.68M → $3.82M (-$2.87M)

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
7
Closed
Calls
Puts
Net Calls
Net Calls Change

HHS Hedge Fund Activity: Q1 2020 in Review

24 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Harte-Hanks (HHS) for Q1 2020, worth a combined $3.82M — down 43% from $6.68M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new HHS positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was William Blair & Company, opening a new position worth an estimated $1.97M. The largest seller was Fondren Management, cutting an estimated $132K.

  • 24 institutional investors held Harte-Hanks (HHS) as of Q1 2020, up from 21 in Q4 2019.
  • Funds reported $3.82M of Harte-Hanks stock for Q1 2020, down 43% quarter-over-quarter.
  • 3 funds opened new Harte-Hanks positions in Q1 2020 and 0 closed out, a net change of +3 holders.
  • The largest Harte-Hanks buyer in Q1 2020 was William Blair & Company, an estimated $1.97M added.
  • The largest Harte-Hanks seller in Q1 2020 was Fondren Management, an estimated $132K sold.

Based on aggregated 13F filings for Q1 2020.